Metoprolol Succinate Tablet, Extended Release
Product Images NDC 68382-565

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 68382-565). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals (usa) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

118706c2 F03f 4175 Aba2 4f0cddb75ae7 01

FDA Label Image

118706c2 F03f 4175 Aba2 4f0cddb75ae7 02

This appears to be a table of results for subgroups in a study called MERITHE. The table includes the headings "Time to First Event" and "Relative risk and 95% confidence interval." The rows appear to compare the effects of Metoprolol and Flacebo on various subgroups, possibly related to heart conditions and heart rate. The table also includes abbreviations for different organizations and medical terms such as "NYHA" and "EF."*

FDA Label Image

118706c2 F03f 4175 Aba2 4f0cddb75ae7 03

This is the label of a medicine bottle containing metoprolol succinate tablets with a dosage of 25 mg meant for extended-release. It specifies storage conditions at a temperature range of 20°C to 25°C and directs to keep the drug away from the reach of children. The medicine is manufactured by Zydus Lifesciences Ltd in India and contains 100 tablets. The label also mentions certain guidelines related to dispensing and the registered trademarks.*

FDA Label Image

118706c2 F03f 4175 Aba2 4f0cddb75ae7 04

This is a prescription drug label with details of Metoprolol Succinate sz tartrate 50 mg. The label includes TIN, SN0, EXP, NDC, LOT, and packaging information. The drug should be stored at a temperature of 20°- 25°C (68°- 77°F) and dispensed in a light container. It contains chemical substances that require it to be kept out of reach of children. The drug is manufactured by Zydus Lifesciences Ltd in Ahmedabad, India for Pharaceuticals (USA)inc.*

FDA Label Image

118706c2 F03f 4175 Aba2 4f0cddb75ae7 05

This is a description of a medication named Metoprolol Succinate, which comes in a film-coated extended-release tablet containing 95mg of metoprolol succinate (equivalent to 100mg metoprolol tartrate). It is used for hypertension or angina. This medication should be stored at 68-77°F and dispensed in a light container. The package is child-resistant, and it should be kept out of the reach of children. This medication is manufactured by Zydus Lifesciences Ltd. in Ahmedabad, India, and is distributed by Zydus Pharmaceuticals (USA) Inc. in Pennington, NJ. There is also an image of the coding template, but the text is not available.*

FDA Label Image

118706c2 F03f 4175 Aba2 4f0cddb75ae7 06

This is a product description of Metoprolol Succinate Extended-Release tablets. The tablets are film-coated and each contain 190 mg equivalent to metoprolol tartrate 200 mg. The package contains 100 tablets and is child-resistant. The tablet is manufactured by Zydus Lifescience in Ahmedabad, India, and distributed by Zydus Pharmaceuticals (USA) Inc. in Pennington, NJ. The recommended dosage and other prescribing information can be found in the package insert. The drug must be stored at 20° to 25°C (68° to 77°F) and out of the reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.